Legal & General Group PLC Sangamo Therapeutics, Inc Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$1.11 - $1.74 $19,887 - $31,175	-17,917 Reduced 57.77%	13,096 $17,000
Q1 2023 May 15, 2023	SELL	$1.66 - $3.67 $47,563 - $105,156	-28,653 Reduced 48.02%	31,013 $54,000
Q4 2022 Feb 14, 2023	BUY	$2.77 - $5.07 $10,370 - $18,982	3,744 Added 6.7%	59,666 $187,000
Q3 2022 Nov 14, 2022	BUY	$4.27 - $6.39 $14,838 - $22,205	3,475 Added 6.63%	55,922 $274,000
Q2 2022 Aug 22, 2022	SELL	$3.28 - $6.21 $4,634 - $8,774	-1,413 Reduced 2.62%	52,447 $218,000
Q1 2022 May 16, 2022	SELL	$5.23 - $7.82 $1,208 - $1,806	-231 Reduced 0.43%	53,860 $313,000
Q4 2021 Feb 14, 2022	BUY	$7.29 - $10.97 $1,975 - $2,972	271 Added 0.5%	54,091 $405,000
Q3 2021 Nov 15, 2021	BUY	$9.01 - $12.01 $215,447 - $287,183	23,912 Added 79.95%	53,820 $485,000
Q2 2021 Aug 12, 2021	SELL	$10.17 - $12.64 $488 - $606	-48 Reduced 0.16%	29,908 $357,000
Q1 2021 May 17, 2021	BUY	$10.88 - $17.05 $29,201 - $45,762	2,684 Added 9.84%	29,956 $376,000
Q4 2020 Feb 12, 2021	SELL	$9.23 - $18.18 $1,559 - $3,072	-169 Reduced 0.62%	27,272 $426,000
Q3 2020 Nov 13, 2020	SELL	$9.38 - $12.48 $45,652 - $60,740	-4,867 Reduced 15.06%	27,441 $260,000
Q2 2020 Aug 14, 2020	BUY	$6.21 - $11.83 $8,954 - $17,058	1,442 Added 4.67%	32,308 $290,000
Q1 2020 May 14, 2020	SELL	$5.05 - $8.85 $25,850 - $45,303	-5,119 Reduced 14.23%	30,866 $197,000
Q4 2019 Feb 13, 2020	BUY	$8.03 - $11.7 $26,739 - $38,961	3,330 Added 10.2%	35,985 $301,000
Q3 2019 Nov 13, 2019	BUY	$9.05 - $12.22 $83,531 - $112,790	9,230 Added 39.4%	32,655 $295,000
Q2 2019 Aug 14, 2019	BUY	$8.75 - $13.03 $26,075 - $38,829	2,980 Added 14.58%	23,425 $252,000
Q1 2019 May 15, 2019	BUY	$7.72 - $12.81 $18,365 - $30,474	2,379 Added 13.17%	20,445 $195,000
Q4 2018 Feb 15, 2019	BUY	$9.51 - $16.6 $14,588 - $25,464	1,534 Added 9.28%	18,066 $208,000
Q2 2018 Aug 10, 2018	BUY	$13.9 - $19.8 $14,581 - $20,770	1,049 Added 6.78%	16,532 $235,000
Q1 2018 May 17, 2018	SELL	$16.7 - $26.35 $98,112 - $154,806	-5,875 Reduced 27.51%	15,483 $294,000
Q4 2017 Feb 13, 2018	BUY	$11.6 - $17.35 $247,752 - $370,561	21,358	21,358 $354,000

Others Institutions Holding SGMO

# of Institutions

111

Shares Held

56.7M

Call Options Held

576K

Put Options Held

1.17M

Wasatch Advisors Inc Salt Lake City, UT

19.4M
Shares

$23.9 Million
0.08% of portfolio
Vanguard Group Inc Valley Forge, PA

9.6M
Shares

$11.8 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

4.85M
Shares

$5.97 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.7M
Shares

$5.78 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.35M
Shares

$2.9 Million
0.0% of portfolio

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $193M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account